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MODELING AND STATISTICAL ANALYSIS OF MEDAKA BIOASSAY DATA
Donald P. Gaver*, Patricia A. Jacobs*
*Department of Operations Research, Naval Postgraduate School, Monterey, CA
93943
ABSTRACT
A histopathologic examination of tissues from Oryzias latipes (Japanese medaka
fish) was performed to evaluate the carcinogenic potential of tricholoroethylene
(TCE) in groundwater. The data were reported by Experimental Pathology
Laboratories, Inc., in a report dated Jan. 19, 1990, submitted to the Army Biomedical
Research and Development Laboratory, Ft. Detrick, MD.
This paper provides a brief statistical analysis of some aspects of those data. The
analysis does not reveal a strong positive relationship between TCE concentration
over the range considered and probability (risk or hazard) of incurring at least one
end point manifestation (here cystic degeneration or liver neoplasm) in a fish.
Uncertainties in the point estimates are assessed by bootstrapping. Both non-
parametric (weak statistical assumptions) and parametric (stronger statistical
assumptions) analyses give similar inconclusive dose-response indications.
A brief discussion is included of a biologically-based mathematical model that is
likely to form an appropriate basis for more sophisticated data analysis.
One contribution of this paper is to discuss and illustrate techniques for
quantitative analysis of other similar data. The methods can also be used to assist in
choosing an experimental design.
INTRODUCTION
The Japanese medaka fish (Oryzias latipes) has come to be of great interest as an
indicator of groundwater toxicity; see Van Beneden et al. (1990), Gardner, et al. (1990).
The Research Model Branch, Health Effects Research Division of the Army
Biomedical Research and Development Laboratory, Ft. Detrick, MD, has conducted
extensive experimentation with medaka so as to test its response to various known
or suspected toxic agents or carcinogens. This paper provides a statistical analysis of
data from such an experiment. Analysis provides a quantitative and focussed
perspective on the message of the data that usefully supplements the more usual
simple qualitative observations.
Design of Experiment
The experiment whose data is analyzed was planned and conducted as follows.
Eight (8) groups of medaka were treated as shown in Table 1. Those groups treated
with DEN received pretreatment with 10 mg/1. of diethylnitrosamine for 48 hours at
17 days after hatch. The groups that received TCE received various concentrations of
trichloroethylene (100%, 50%, 25% and 0%) on a biologically-motivated scale: 100%
refers to undiluted groundwater containing TCE, and 50% and 25% refer to
correspending with pure water.
TABLE 1
TREATMENT COMBINATIONS AND CD RESPONSES
# fish with symptom/# fish
killed
Sacrifice Time
Group DEN no DEN %TCE 3 months 6 months
1 X 6/25 4/15
3 X 25 4/25 5/13
5 X 50 2/25 4/14
7 X 100 3/25 3/14
2 X 11/25 6/12
4 X 25 4/25 8/13
6 X 50 6/25 5/12
8 X 100 7/25 3/8
The individual fish were assigned to tanks of water, presumably maintained at
standard temperature, also presumably in a random manner. There do not appear to
have been replicate tanks. After three months an interim sacrifice was made of 25
fish in each group; the number of fish showing cystic degeneration (CD), after three
months/six months appear to the left of the slash (/) in the table. Thus Group 1
contained six fish out of 25 with CD after three months, and four out of 15 after six
months; in the latter case 15 fish were exposed to the original concentration for the
entire six months; this is referred to as the chronic group. Another group, the so-
called recovery group, was placed in pure water for the second three month period.
This group's response is not analyzed in this paper. Table 2 reports the incidence of
liver neoplasms for the same fish in groups 2, 4, 6, 8 that were pretreated with DEN.
TABLE 2
INCIDENCE OF LIVER NEOPLASMS IN MEDAKA FOR GROUPS PRETREATED
WITH DEN
# fish with symptom/# fish killed
Sacrifice time
Group %TCE 3 Months 6 Months
2 0/25 1/12
4 25 2/25 3/13
6 50 0/25 1/12
8 100 2/25 4/8
Model-based Analysis
The experimental outcomes are viewed from the following perspective. Each
individual fish subjected to a particular DEN-TCE treatment (e.g., DEN = 0,
TCE = 50%) is initially thought of as a member of a population of similar fish. For
various reasons, including that of genetic diversity, the individual fish will exhibit
particular symptoms, i.e., reach specified biological endpoints such as cystic
degeneration or neoplasm within specified organs, at widely different times. In
addition some fish may die before any such symptoms manifest themselves.
Consequently it is reasonable and natural to think of the occurrence of a particular
endpoint as a probabilistic (or random, or stochastic) phenomenon, much as a
coinflip or dice throw outcome is thought of, or in the same way that actuarial
scientists regard human life durations when proposing life insurance contracts. That
is, let T, the time to occurrence of a particular endpoint,such as cystic degeneration,
be a random variable, a quantity whose value (for a particular fish) is determined by
sampling from a population with a fixed distribution function that in turn depends
upon the treatment of interest (DEN and TCE), but also upon water temperature and
presence of other elements in the fish tank, and also individual fish traits. This
distribution function is
Population Fraction of Fish with Symptom
Times, T, less than t(t = 3 months, 6 months) = C(r,9)
The population parameter values that identify the particular distribution are called
9 = (0\, 62, •••, Op)- For instance, 6\ might be the population mean, and 62 the
population standard deviation. Occasionally the specific distribution used to model
the variability in a population of times is normal, i.e. its density function
g(t;e) = dG/dt
the familiar bell-shaped curve:
= e 2




However, more frequently that data variability is better described as log-normal:
logarithm of T = X has a bell-shaped density for the raw T-values tend to straggle off
to the right, i.e. the density of T is (possibly) "positively skewed." A simpler form
that may be appropriate is the exponential:
In this model A = l/(Mean time to exhibit symptoms, e.g., CD). We will later use this
exponential model in an illustrative analysis. Still another form that may be
appropriate for describing the time to the onset of a cancerous growth is the Weibull
which describes an increasing, or decraesing, time of exposure effect, depending
upon data requirements. Later we shall describe a distribution that arises from
plausible biological assumptions, particularly when cancer is considered—the
Moolgavkar family of clonal expansion models; Moolgavkar et al. (1979). Use of the
latter "biologically-based" family requires that at least four parameter values be
estimated from data. In the light of the current experimental design such models are
somewhat difficult to identify. The exponential distribution will be used in this
report to illustrate a parametric analysis (one using a specific assumed form for
ami
Use of the Conceptual Model
Since TCE is a toxic substance it might be anticipated that (a) the mean or
average fraction of fish exposed to x% of TCE that exhibit symptoms after t = 3
months (the first three months) would increase with x (the TCE concentration);
likewise for six months of (chronic) exposure; and (b) that the mean fraction of the
fish that survive the first three months that exhibit symptoms in the second three
months (between three months and six months of exposure) might increase over the
mean fraction in the first three months. The latter behavior would imply an
increasing hazard property attributable to dosage with TCE. The increasing hazard
property is consistent with the idea that prolonged exposure (to TCE here) increases
the chances that particular endpoints will occur as time goes on. However, evidence
for such behavior from the current data is not strong in the light of the uncertainties
associated with sampling errors as assessed by bootstrapping.
NON-PARAMETRIC ANALYSIS
Suppose the above general sampling model prevails. Then an estimate of the
probability that a fish exhibits a particular symptom, e.g., CD, within time t (= 3
months) is
Estimate of Probability -
That T < t (= 3 months) = G <3 '6)
Number of Fish Sacrificed at t( = 3) that Exhibit Symptom (e.g., CD) '
Number of Fish Exposed (for t = 3)
This estimate is easily calculated for all treatments; however sometimes it is zero.
This suggests that the number of fish exposed is too small to be detectably influenced
by the dosage; in general we might expect some response. Since G(3;0) is the so-called
hazard associated with the appearance of the particular symptom during the first
three months of exposure, G(3;0) is an estimate thereof on the basis of only 25
exposed fish; for a different 25 fish treated equivalently we generally anticipate a
different numerical value of G. By re-sampling ("bootstrapping) it is possible to
appraise the sample variation in the estimate G: sample from a binomial
distribution with G being the probability of "success" = symptom occurrence within t
= 3, and N(= 25), the number exposed, to obtain a pseudo or bootstrapped sample
number of fish exhibiting the symptom, and from this, divided by N, a possible
sample value of hazard, i.e., G\. Repeat to get Gi, again to obtain 63,..., Gb, where B
is "large." The sampling has been repeated B = 500 times. Then compute
1 £ 2
Variance G = -p\ (O, — Gb)Bw
and the standard error of the original estimate, G, isSE[G] = \ variance G where Gg
is the sample mean of the bootstrap estimates; Gg = J. ,Gj, / B. For the first three-
month data the above standard error can actually be calculated directly (no re-
-
. /GO - G)
sampling necessary): SE[G] = \J —rj , but this formula approach is not so easy
for the second three-month period. Roughly speaking, the true value of G(3) lies
within G-2SE[G] and G + 2SE[G]. So an estimate, and an error estimate, for initial
three months hazard is obtained. See Table 3 for quoted estimates and standard
errors (in parentheses).
To compare to the second three months' hazard compute
Estimate of Probability
That T<t = 6 Months, G(6,0) - CO,6) -
Given that T > t = 3 Months = — — = G(6,3;0»
1-C(3;0)
= Estimate of Second 3-Months' Hazard.
Notice that the estimates G(6;6) and G(3;0) must be obtained from different sets of
counts, just as was done earlier, and consequently that there is no guarantee that
G(6;6) is greater than G(3;0). Although no case of such reversal occurs in the present
data, a few reversals have occurred when resampling or bootstrapping is done; in
such cases the hazard value is set equal to zero. Standard errors of the second 3-
months' hazards are calculated by bootstrapping G(6,2;0) by resampling for each
component, G(6;60and G(3;6), and combining as in the formula above.
Tables 3 and 4 summarize the results of the point estimates and their standard
errors. Table 3 refers to CD, while Table 4 addresses neoplasms. Figures 1 through 5
graphically display the actual hazard sampling variations as assessed by
bootstrapping. Figures 1-3 present boxplots of the bootstrap sample hazards Gfc(3;#)
and Gfc(6,3;0)
.
The following description of the boxplot is taken from the documentation of
GRAFSTAT, a developmental product of IBM which the Naval Postgraduate School
is using under a test agreement with IBM. 'The box portion of the plot extends from
the lower quartile of the sample to the upper quartile. (The lower quartile is the
point for which one quarter of the sample lies below and three quarters above. The
upper quartile is analogous.) The line across the center of the box marks the median.
The circle in the box represents the mean.
The distance from the lower to the upper quartile is called the interquartile
distance, and it will be represented by Q. The points at the ends of the two lines
(called whiskers) are the smallest and largest points, respectively, within 1.5Q of the
quantiles. The points beyond the whiskers are outlying values."
Figures 1 and 2 present the boxplots for the CD hazards. Figure 3 presents
boxplots for the neoplasm. The boxplots are grouped by level of TCE which is
indicated at the bottom of the figure. The left boxplot in each grouping is for the 3
month hazard. The right boxplot in each group is for the 6 month hazard.
Comparison of the boxplots for the 3 and 6 month hazards in Figures 1 and 2
suggests that the 3 and 6 month hazards are roughly the same. Comparing Figures 1
and 2 suggests that the pretreatment with DEN tends to increase the hazard.
Comparison of the 3 and 6 month boxplots in Figure 3 suggests the respective
hazards are the same except for the 6 month hazard at the 100% TCE level, which
appears to be somewhat higher than the others for neoplasms.
Figure 4 presents the histograms of the CD hazard bootstrap samples. Once
again the major effect seen is the increase in hazard for the fish pretreated with DEN.
Figure 5 presents the histograms of the neoplasm hazard bootstrap samples.
Once again the only histogram that appears different is the histogram for the 6
month hazard at 100% TCE.
Conclusions
The general conclusion from the above analysis is that there is only a weak effect
from TCE treatment change, regardless of whether DEN is used. The effect of DEN is
noticeable: the second 3 months' hazard is always somewhat larger when DEN is
used than is the case with no DEN. This is anticipated, but the quantitative degree of
enhancement may be of interest.
TABLE 3
NONPARAMETRIC HAZARD FOR CYSTIC DEGENERATION
(BOOTSTRAP STANDARD ERROR)
Estimated Hazard
(Standard Error) Wpq/25 J
Sacrifice Time










































NONPARAMETRIC HAZARD FOR NEOPLASMS
(BOOTSTRAP STANDARD ERROR)
Estimated Hazaid_
(Standard Error) [^pq/25 \
Sacrifice Time


















In the present context a parametric analysis of data means that a particular
mathematical form is adopted for the distribution of T, the time to symptom
occurrence. It is desirable that such a form have a plausible biological origin, i.e. that
it can be derived from suitable biological considerations, and that it adequately
represent the data. The Moolgavkar et al. models (1973), (1979), (1983) seem to satisfy
the former requirement, but involve at least four parameters, which is too many to
attempt to fit using data from the present design. Instead, the simple exponential
distribution,
has been adopted for illustration. Note that the single parameter, A, is actually
interpretable as the inverse of the mean of T (time to symptom occurrence) in the
population. If this model agrees reasonably well with the data then 1 /estimated
A=l/Ais easily understood and interpreted. The exponential model also implies
that the theoretical first and second 3 month hazards are the same. Notice that since
no actual times to symptom appearance are ever observed such a quantity is not
available from non-parametric methodology. The parameter A (actually it is best to
estimate y= log A) must be estimated from the counts at three months and six
months. The method used here is that of maximum likelihood; details are provided
in an appendix.
Tables 5 and 6 exhibit the results of the analysis.
These results seem surprising, since mean time to exhibit the CD symptom
appears to increase with TCE dosage; as anticipated the effect of DEN is to reduce the
time to symptom appearance; these results are in rough qualitative agreement with
the non-parametric results. See also Figures 6-7, which indicate the uncertainty
associated with the above numerical values. These results were obtained by
bootstrapping.
Figure 6 displays boxplots of the values of
-y, the log mean time to CD for the
bootstrap samples. Once again the boxplots are grouped in pairs by level of TCE
which is indicated on the bottom of the figure. The leftmost, (respectively
rightmost), boxplot in a group is for the fish not pretreated with DEN, (respectively
pretreated with DEN). Once again the major effect is a decrease in mean time to
occurrence of CD with pretreatment with DEN. The variability of the estimate
makes other conclusions suspect. Figure 7 displays the histograms of the bootstrap
estimate values of the
-y, the log mean time to CD.
Figures 8-9 present boxplots comparing the bootstrap estimates of the probability
that CD occurs before 3 months obtained from the parametric exponential model and
the nonparametric analysis. The estimate for the probability using the exponential
model is
TABLE 5
MAXIMUM LIKELIHOOD ESTIMATES OF MEAN TIME TO EXHIBIT CD
(BOOTSTRAP STANDARD ERROR)
Group DEN no DEN %TCE Log Mean Time to CD JCD
occurs 1
{before 3 months}




































































pe = l-exp|-e r
3J.
The estimate of the probability using the nonparametric hazard is the average of the
first and second 3 month hazard. The boxplots are grouped by level of TCE. The left
(respectively right) one in each group are the bootstrap estimates for the parametric
exponential model (respectively the nonparametric hazard). The figures suggest that
the two procedures yield roughly the same estimate.
Figure 10 presents similar boxplots for the bootstrap estimates of the probability
the neoplasms occur before 3 months. Note that the exponential model estimates
suggest that there is no effect at 100% TCE. Note that only the chronic data is being
examined.
Figure 11 present histograms for a simulation experiment to illustrate the effect
of using more fish in the experiments. Our experiment is extreme in that 200 fish
are used in each group; 100 are sacrificed at 3 months and 100 sacrificed at 6 months.
The nonparametric estimates of G(3;0) and G(6;0) for each group of the CD data are
used as the true probabilities of CD occurring at 3 and 6 months respectively. For
each simulation replication 2 random numbers are drawn; one from a binomial
distribution with 100 trials and probability the estimate of G C3;9) and the other from
a binomial distribution with 100 trials and probability the estimate of G (6;9). For
each group 500 simulation replications are done and the two 3 month hazards are
computed for each replication as before. A comparison of the histograms in Figures
4 and 11 shows the amount of decrease in the variability of the estimates that can be
achieved by increasing the number of fish used in the experiment.
BIOLOGICALLY-BASED MODEL DESCRIPTION
It is widely believed that pre-cancerous conditions in an organ (the liver) occur
as a result of cell clonal expansion, followed by a promotion (to tumor) event.
Specific models for this have been proposed and developed by Moolgavkar and co-
workers. More recent work is by C. J. Portier and co-workers. References appear
later.
The basic mechanism is treated as random or probabilistic: an initiating event,
e.g., caused by contact with toxin, affects a cell within an organ in accordance with a
simple Poisson process with rate parameter A. That is, the chance of an uninitiated
cell being initiated in time interval (t, t+h) is approximately kh. If a cell is initiated
during exposure time it clones itself into other cells at rate ft; the original cells and
its clones die randomly at rate <5. All cells in the organ perform thus independently,
according to the model. Depending upon the values of /3 and 8 (birth and death rates
respectively) a colony of initiated cells (pre-cancerous, presumably) either tends to
grow exponentially, or to die off to zero (also exponentially fast). The fates of
colonies characterized by the same values of birth rate and death rate may actually be
entirely different, as befits experience with variability characteristic of the real
biological world. This behavior is roughly analogous to that of the flipping of the
same coin: on one occasion 10 flips may well result in an excess of 5 Heads (7 Heads
10
and 3 Tails), analogous to more births (Heads) than deaths (Tails); on another
sequence of 10 flips with the same coin the result may be exactly reversed (7 Tails, 3
Heads). Processes analogous to coin flipping or dice rolling can describe much, but
possibly not all interesting biological variability pertinent to risk analysis. Other
options are suggested later.
The values of /3and 8 describe clone colony properties in a precise probabilistic
manner if the model is correct. It is certainly only approximate, but may still provide
a useful tool for quantifying risk of tumor formation. The second step in the
malignant cell development process is postulated to be promotion. A model for this
is that at rate /z, i.e. with probability /x/i in time (t, t+h), a promotion event occurs that
affects one of the clone colony members in proportion to the current size of the
colony; such events are assumed to occur in accordance with a Poisson process with
rate proportional to instantaneous clone population size. At the instant that the first
such promotion event occurs, the clone colony (if one exists, i.e. has been initiated)
will be said to have developed a tumor, at least in informal layman's terms. Note
that all original cells in an organ are assumed to be independently exposed to
initiation and, thereafter, to promotion. Therefore all organ cells and subsequent
clones, if any, must survive from initiation to the end of the observation period
without being promoted in order for the organ to survive throughout.
The probabilistic mechanism described has been used to obtain a formula for the
survival probability for an organ for any observation time t. See Appendix B for the
formula and its derivation. Similar formulas have been derived also by Moolgavkar
and others. Our formula provides the basis for statistically estimating from
pathology data, (combinations of) the parameters: X, the initiation rate; /i, the
promotion rate; and /Jand 8, the clonal birth and death rates. Such estimates can, in
turn, be used to estimate the probability of cell, and organ, survival for any time
period. Appendix A contains a discussion of maximum likelihood estimation from
data so as to specify parameters of a preliminary model. Further work is required to
obtain additional statistical models and procedures to analyze other experimental
data.
Extensions to the Model: Extra-variation of Parameters
The above model, and the consequences thereof in the form of a survival
probability function, are appealing since they have a plausible biological basis.
Organ-to-organ outcomes (tumor occurrence or not) vary randomly, but according to
precisely the same mechanism in each organ; i.e. the same values of X, n, (3 and 8 are
assumed to hold for each organ. Note that this ignores likely variability between
organs in different subjects (e.g., fish). Different, but superficially identical, biological
entities, be they fish, rats, or humans, can be expected to have some differences; these
can be said to be the result of genetic diversity. Specifically these differences may
cause the effective parameters X, /i /3 and 8 to differ substantially across animals. //
the above are estimated from data without recognizing the possibility of extra-
variation, biased results will be obtained. See Harris (1990) for biological
explanations of inter-organ (subject) variability.
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There are several possible simple and preliminary ways of dealing with the
above problem. One is by attempting to "explain" parameter variation by
representing it as a function of some causal variable, such as the age, sex, weight, etc.,
of the host subject. The technique is a variation of ordinary regression analysis;
methods of McCullagh and Nelder (1983) suggest themselves. A description of a
preliminary computational procedure to estimate model parameters is described in
Appendix A. This procedure is used to estimate model parameters for a particular
data set. A second approach is to assume that the variability between individual host
organs can be represented by treating some or all of the parameters as random
variables with their own distributions. A typical survival function is then obtained
by mixing: the parametric survival function of Appendix B is "simply" randomized
according to the (joint) distribution of the parameters. In principle it is desirable to
recognize both sources of variability between individuals, adjusting for known
sources of variation by a regression technique where possible, but recognizing the
"unexplainable" variation by use of a mixing technique. The latter has been carried
out to a limited extent, see Gaver and Jacobs (1992).
CONCLUSIONS AND SUMMARY
This report covers an initial short piece of research conducted under the
sponsorship of the Army Biomedical Research and Development Laboratory. Its
main contribution is to propose and illustrate quantitative assessments of treatment
(here groundwater concentration) effects upon medaka. Those quantifications
include the estimation of statistical sampling errors by the re-sampling or
bootstrapping technique.
The somewhat inconclusive dose-response relationships revealed seem to
imply the need for more sensitive experiments. Possibly such sensitivity can be
achieved by working with more genetically homogeneous animals (medaka).
Possibly, larger numbers of animal subjects will be helpful as well. Control and
measurement of experimental conditions (e.g., tank temperature) and adjustments
for their variations can play a useful part in the investigation.
It is hoped that the mathematical and statistical approaches illustrated here will




MODEL FITTING METHODS FOR QUANTIFYING BIOASSAYS
PRELIMINARY STATISTICAL MODELS AND METHODS FOR ANALYZING
BIOASSAY DATA
Suppose N organisms (for example fish) are used in an experiment. Groups of
these organisms may be exposed to different treatments. Let T- be the random time
until organism i develops a particular symptom, e.g., cystic degeneration. Let
Xj = (Xyp X^, .../ X- ) be covariates which (possibly) influence T
t
; the X- could be
levels of substances having possible toxic effects to which the organisms are exposed.
Let Git; xp = P [Tj- < t IX,- = x^ ]. We will assume that the organisms develop symptoms




organisms are sacrificed at time t
k
with r, < f2 < ••• < tv We
will label the organisms so that organisms 1 through n
x
are sacrificed at time f
T
;
organisms fl-,+1, ..., n^ + n
2
are sacrificed at time t
2 ;
etc. Let s- = 1 if organism i
exhibits the symptom when it is examined. Under the assumption of independence,
the likelihood function is





where w = ^ an<^ G(f; x) = 1-G(f; x). The likelihood functions form the basis for
estimation of parameters in the distributions that model survival times, i.e. G.








where fk is the number of the n k organisms exhibiting the symptom.
A procedure to estimate the parameters of the distribution G for the simple
binomial model is as follows.
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MAXIMUM LIKELIHOOD ESTIMATION IN THE SIMPLE BINOMIAL MODEL
(a) Likelihood and Parameter Estimation Formulas
Assume the distribution of the time to appearance of a symptom, G, is a
function of the parameters , j = 1, ..., J. In this section we discuss maximum
likelihood estimation of for the simple binomial model. Presumably the n k
subjects examined at time t k , k = 1,2, ..., K have all been subjected to a common
dosage of a potential toxin. The purpose of the present analysis is to predict survival
probabilities as they depend on such dosage. The log-likelihood function for the




=T^{ nf"yfk^G(tk ;Q) + (nk -fk )\nG(tk ;Q) (A3)
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G(t k ;B)G{tk ;Q) 30,
G(tk ;Q). (A.4)
Since E[ik ]=n kG(tk ;Q)
dQjdem








Thus a Newton procedure for finding the maximum likelihood estimates of





where 6 =(0|,...,0j . Such iterative procedures can be programmed for a digital
computer, and the resulting parameter values can be used to compute predictions for
survival probabilities, or risk, as the latter depend upon the parameters of such
models as described in Appendix B.
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APPENDIX B. TWO-STAGE CLONAL-EXPANSION MODEL
In this appendix we present a birth-death model for the distribution of time
until a normal cell becomes promoted to a tumor.
We first develop an expression for the distribution of random time, S, until an
initiated cell or one of its descendants becomes malignant.
Assume that there is one initiated cell at time 0. Such cells divide at an
exponential rate /3, and die at an exponential rate 8. Any initiated cell turns
malignant at an exponential rate fj.; i.e. fi is the promotion rate.
(a) Time to Promotion of an Initiated Cell
Let S be the random time at which some initiated cell or its descendent turns
malignant; note that S may actually be infinite if the population of initiated cell and
its descendents dies out. Put
z(t) = P{S>t}.
The following probability argument provides an equation for z(t): the event that
S > t+A (A > 0) occurs if (i) neither birth (cloning), death, or promotion occurs in
(0, A) and promotion does not occur in (A, t+A); the probability of this is
[1 - {fi+&+Li)A + o(A)]z(t); or (ii) birth/cloning occurs in (0,^) and no promotion occurs
in (A, t+A); the probability of this event is [@A + o(z\)]z 2 (0, where the square
recognizes that at time A there are now two independent clonal families to be
considered; or (iii) the original initiated cell dies in (0, A), the probability of which is
SA + o(A). Sum these three terms to obtain the probability that S > t+A:
z(t + A) = (M/3 +5 + li)A)z{t) + pAz2 (t) + SA.
Now subtract z(t) from each side, divide by A and let A —> 0. The result is the
differential equation
^ = -(p + 8 + ^)z(t) + Pz 2 (t) + S (B.l)
Hence z{t) satisfies a Riccati equation with initial condition
2(0) = 1 (B.2)
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where p T 2 are the solutions to the quadratic equation
f * 8 P
















Since V+73+73/ _4B ^ \1 +73+ ft), both pj and p2 are positive. Further
p2 < 1 and
Pi " P2 =
1
5 P] A S




lim z(f) = P2- (B.6)
If the death rate 5=0, then p = and lim PfT > t } = 0; if 8 = 0, then there is no deathz
t -»«,
of initiated cells and thus an initiated cell will transition to a malignant cell in a
finite time with probability 1. If <5> 0, then the initiating cells can die, thus
preventing a transition to malignancy and hence lim P{T> t} = p2 >0.
t —> °°
(b) Model for the Time until a Normal Cell becomes Malignant (is Promoted to
Tumor)
Assume that each normal cell is initiated at an exponential rate Aq. Let N be the
total number of normal cells in an organ. Let T denote the first time a normal cell
transitions to a malignant cell.
17
-iN
P{T>t} = e~XOt +ix e~XOSz{t-s)ds (B.7)
where 2 is a given in (B.3). Assume Aq is small and put X = XqN, a constant. Then
t
P{T > t} « exp Nln N £J 2(s)* (B.8)
= exp
t
. z(s)ds-Xt + X I (B.9)
= exp A(Pl -l)f-A-ln
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